Overcoming bio/pharmaceutical production hurdles: an industry insider perspective
Partnership speeds the development of pressurised metered dose inhalers
Recipharm’s analytical lab brings testing capabilities to global markets
Arranta Bio signs contract for continuous mRNA manufacturing tech
Recipharm appoints Joaquim Mascaro as Chief Financial Officer
BES completes $4.8m refurb for Recipharm
Recipharm extends commercial manufacturing for RedHill’s drug
What does 2023 hold for oral solid dosage forms?
Recipharm bolsters blow-fill-seal capabilities with Lab+
Managing the next pandemic: how prepared are we?
Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine
Recipharm expands services for pMDI propellants
Recipharm completes two acquisitions
Recipharm invests in high-speed filling line for aseptics
Recipharm expands ATMPs capabilities with CDMO acquisition